Investor · 6 deals
Every published round Pavilion Capital took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
Companies Pavilion Capital has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Allay Therapeutics | 16 Sep 2021, Series C | 1 | 0 | |
| Rokt | 2022, Series D+ | 1 | 0 | |
| Doctor Anywhere | 7 Apr 2022, Series B | 1 | 0 | |
| Vow | Cultured meat and novel food products grown from animal cells | 14 Nov 2022, Series A | 2 | 0 |
| Fleet Space Technologies | 24 May 2023, Series C | 1 | 0 |
This is a stake in the fund itself, money that the fund's manager invests, not a stake in the fund manager.
Companies Pavilion Capital has backed that another company then bought. An exit for the holding, not a deal Pavilion Capital did.
Stories naming Pavilion Capital. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Investors bought existing Rokt shares in a tender at a higher valuation; the piece also reports the mParticle acquisition, a board addition, and past raises.
Manufacturing news roundup: Fleet Space's oversubscribed Series C, a grant-backed 3D printing research project, an agreed brand acquisition, equipment orders, a cargo drone first flight and industry awards.
Weekly roundup of five startup raises: Fleet Space's Series C, Checkmate's Series A, Adventus's new round, Endua's hydrogen funding and Servicely's raise, with investors named.
Also Forbes Australia
Square Peg and Wellington Management bought more shares of Rokt from employees and investors in a secondary sale, lifting its valuation, while its earlier funding rounds are recapped ahead of a planned IPO.
Also Forbes Australia
Cultivated meat maker Vow raised a Series A to fund product development, manufacturing expansion and hiring as it prepares to launch its quail product in Singapore restaurants.
Also TechCrunch Venture·TechCrunch Venture·TechCrunch Venture·AgFunderNews·AgFunderNews·AgFunderNews·TechCrunch Venture
Rokt raised a record A$458 million Series E led by Tiger Global, valuing it at $2.75 billion, while employees and investors sold down shares; the founder aims for a US listing in 2023.
Rokt's Series E tops a week of Australian raises including Dovetail, Inventia, DiviPay, Atomi, 6clicks, Replica Studios and ProForm Foods, with SimPro's recent raise noted.
US-Singapore biotech Allay Therapeutics has closed a $60 million Series C round led by Arboretum Ventures, with several healthcare investors taking part, to advance its long-acting post-surgical pain candidate into late-stage trials.
Blackbird Ventures has closed a $500 million fourth fund backed by Australian institutional and international investors. The article recalls Square Peg and Tidal Ventures raises, Our Innovation Fund's new fund, and Amazon's Zoox acquisition.
Also SmartCompany
Blackbird announces the close of its fourth fund at $500 million, bringing total committed capital to $1.24 billion, and separately announces Mike Cannon-Brookes joining its board as chair.
Also Blackbird Ventures portfolio·SmartCompany·Startup Daily·Startup Daily·Startup Daily